Publication of List of Manufacturers Granted Licence for the Manufacture of Therapeutic Goods – 9 April 2024

Overview

The Therapeutic Goods Act 1989 was enacted to provide a legislative framework for the regulation of therapeutic goods in Australia, addressing the need for ensuring the safety, quality, and efficacy of these products. The Act was introduced to manage the importation, manufacture, and supply of therapeutic goods, thereby protecting public health. The Therapeutic Goods Administration (TGA), which operates under the Department of Health and Aged Care, is the enacting body responsible for administering the Act. The policy objective of the Act is to safeguard the health and safety of the Australian public by ensuring that therapeutic goods are of acceptable quality and do not pose unacceptable health risks. This legislation thus establishes the foundational structure for the oversight and regulation of therapeutic goods in Australia.

Scope and Application

The Therapeutic Goods Act 1989 applies to entities involved in the manufacture, supply, and distribution of therapeutic goods within Australia, which includes medicines, medical devices, blood, and tissues. The Act mandates that these entities obtain the necessary licences and approvals from the Therapeutic Goods Administration (TGA). The Act applies to all therapeutic goods, regardless of whether they are manufactured within Australia or imported, ensuring that the quality, safety, and efficacy of these goods are maintained to a high standard. The Act's jurisdictional reach extends throughout the Commonwealth of Australia, encompassing all states and territories. Notably, the Act does not apply to therapeutic goods that are exempt under the regulations, such as certain over-the-counter items and products for personal use like cosmetics and vitamins. The Act’s application can be further extended or restricted through subordinate instruments, such as regulations and guidelines issued by the TGA.

Key Provisions

The Therapeutic Goods Act 1989, as referenced in Section 38, outlines the requirements and processes for the licensing of entities that manufacture therapeutic goods. According to this section, the Secretary of the Department of Health and Aged Care, Therapeutic Goods Administration, has the authority to grant licences to specific entities for the manufacture of therapeutic goods. This legislation requires that the grant of such a licence must be published in a formal notice, as evidenced by the document published on 9 April 2024. The licence details, including the names and addresses of the entities granted the licence, are published to ensure transparency and accountability in the manufacturing process of therapeutic goods. Entities granted a licence under this Act have several obligations and requirements to adhere to. These include, but are not limited to, ensuring that their manufacturing practices meet the quality and safety standards set by the Therapeutic Goods Administration. Licensed manufacturers must maintain records of their manufacturing processes, keep detailed records of all therapeutic goods produced, and ensure that all products meet the necessary standards before distribution. Additionally, these entities must comply with any additional conditions or requirements that may be imposed by the Secretary as part of their licence. The Act also imposes potential consequences for non-compliance with its provisions. Offences under the Therapeutic Goods Act 1989 can include manufacturing therapeutic goods without a valid licence, or failing to adhere to the conditions of a licence. Such offences may result in civil or criminal penalties. For example, an individual or entity found guilty of manufacturing therapeutic goods without a licence may face substantial fines or imprisonment. The specific penalties can vary depending on the severity and nature of the offence, but they can include fines of up to $220,000 for individuals and $1,100,000 for corporations, along with potential imprisonment terms. The Act also provides for the cancellation of a licence if the Secretary determines that the licence holder has breached the conditions of their licence or the Act itself.